BCMA‐negative or BCMA‐low MM cells are implicated as a reservoir of treatment‐resistant disease preceding relapse in recent clinical investigations of cellular therapies and maybe one of several mechanisms responsible for relapse.14, 15. The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.